ProCyte Corporation (OTC Bulletin Board: PRCY), is the maker of Tricomin Therapy Spray, Tricomin Shampoo, and Tricomin Conditioner. They are a leading developer and marketer of proprietary products for the skin health, hair care, and wound care markets, today reported its resultsfrom operations for the third quarter ending September 30, 2000.
Revenues for the quarter increased 75% to $1,662,906 as compared to $948,915 for the same period a year ago. The Company finished the quarter ended September 30, 2000, with $3,144,132 in cash.
Growth in the quarter was driven by continued strong sales of the Company’s proprietary products, such as Tricomin hair loss products. Proprietary product sales increased 58% in the third quarter to $1,310,753, as well as a 187% jump in revenue from contract manufacturing, licenses, and royalties.
“Our business continues to show solid revenue growth due to our aggressive sales and marketing campaigns,” commented Jack Clifford, Chairman and CEO of ProCyte Corporation. “This is an exciting time in the Company’s history, as a number of our efforts are beginning to translate into revenue. We are beginning to realize more revenue from a larger percentage of our distributors and licensees, which should
continue to drive growth in the coming quarters.